BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 20022984)

  • 1. IgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiency.
    Villalta D; Tonutti E; Prause C; Koletzko S; Uhlig HH; Vermeersch P; Bossuyt X; Stern M; Laass MW; Ellis JH; Ciclitira PJ; Richter T; Daehnrich C; Schlumberger W; Mothes T
    Clin Chem; 2010 Mar; 56(3):464-8. PubMed ID: 20022984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against deamidated gliadin as new and accurate biomarkers of childhood coeliac disease.
    Prause C; Ritter M; Probst C; Daehnrich C; Schlumberger W; Komorowski L; Lieske R; Richter T; Hauer AC; Stern M; Uhlig HH; Laass MW; Zimmer KP; Mothes T
    J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):52-8. PubMed ID: 19465869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients.
    Mozo L; Gómez J; Escanlar E; Bousoño C; Gutiérrez C
    J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):50-5. PubMed ID: 22197936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of IgG and IgA antibodies against native gliadin is not helpful for the diagnosis of coeliac disease in children up to 2 years old.
    Richter T; Bossuyt X; Vermeersch P; Uhlig HH; Stern M; Hauer A; Zimmer KP; Mearin L; de Roo JH; Dähnrich C; Mothes T
    J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):21-5. PubMed ID: 22249805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies.
    Sayed SK; Imam HM; Mahran AM; Refaiy AM
    Egypt J Immunol; 2012; 19(2):41-52. PubMed ID: 23885406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children.
    Basso D; Guariso G; Fogar P; Meneghel A; Zambon CF; Navaglia F; Greco E; Schiavon S; Rugge M; Plebani M
    Clin Chem; 2009 Jan; 55(1):150-7. PubMed ID: 18988751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of IgG anti-deamidated gliadin peptide antibody assays is comparable to IgA anti-tTG in celiac disease.
    Vermeersch P; Geboes K; Mariën G; Hoffman I; Hiele M; Bossuyt X
    Clin Chim Acta; 2010 Jul; 411(13-14):931-5. PubMed ID: 20171961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological assessment for celiac disease in IgA deficient adults.
    Wang N; Truedsson L; Elvin K; Andersson BA; Rönnelid J; Mincheva-Nilsson L; Lindkvist A; Ludvigsson JF; Hammarström L; Dahle C
    PLoS One; 2014; 9(4):e93180. PubMed ID: 24709954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic efficacy of the ELISA test for the detection of deamidated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease.
    Tonutti E; Visentini D; Picierno A; Bizzaro N; Villalta D; Tozzoli R; Kodermaz G; Carroccio A; Iacono G; Teresi S; La Chiusa SM; Brusca I
    J Clin Lab Anal; 2009; 23(3):165-71. PubMed ID: 19455636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing for IgG class antibodies in celiac disease patients with selective IgA deficiency. A comparison of the diagnostic accuracy of 9 IgG anti-tissue transglutaminase, 1 IgG anti-gliadin and 1 IgG anti-deaminated gliadin peptide antibody assays.
    Villalta D; Alessio MG; Tampoia M; Tonutti E; Brusca I; Bagnasco M; Pesce G; Stella S; Bizzaro N
    Clin Chim Acta; 2007 Jul; 382(1-2):95-9. PubMed ID: 17490629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of IgA anti-tissue transglutaminase antibody assays in celiac disease patients with selective IgA deficiency.
    Villalta D; Alessio MG; Tampoia M; Tonutti E; Brusca I; Bagnasco M; Pesce G; Bizzaro N
    Ann N Y Acad Sci; 2007 Aug; 1109():212-20. PubMed ID: 17785308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing celiac disease: a comparison of human tissue transglutaminase antibodies with antigliadin and antiendomysium antibodies.
    Baudon JJ; Johanet C; Absalon YB; Morgant G; Cabrol S; Mougenot JF
    Arch Pediatr Adolesc Med; 2004 Jun; 158(6):584-8. PubMed ID: 15184223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis of celiac disease in IgA deficient children: contribution of a point-of-care test.
    Bienvenu F; Anghel SI; Besson Duvanel C; Guillemaud J; Garnier L; Renosi F; Lachaux A; Bienvenu J
    BMC Gastroenterol; 2014 Nov; 14():186. PubMed ID: 25376178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.
    Agardh D
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1276-81. PubMed ID: 17683995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA anti-tissue transglutaminase antibodies and IgG antibodies against deamidated gliadin peptides as predictors of celiac disease.
    Ortiz G; Messere G; Toca MDC; Fiorucci M; Bigliardi R; Vidal J; Reynoso R
    Arch Argent Pediatr; 2019 Feb; 117(1):52-55. PubMed ID: 30652447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease.
    Van Meensel B; Hiele M; Hoffman I; Vermeire S; Rutgeerts P; Geboes K; Bossuyt X
    Clin Chem; 2004 Nov; 50(11):2125-35. PubMed ID: 15388634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease.
    Olen O; Gudjónsdóttir AH; Browaldh L; Hessami M; Elvin K; Liedberg AS; Neovius M; Grahnquist L
    J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):695-700. PubMed ID: 22722680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides.
    Kasperkiewicz M; Dähnrich C; Probst C; Komorowski L; Stöcker W; Schlumberger W; Zillikens D; Rose C
    J Am Acad Dermatol; 2012 Apr; 66(4):583-8. PubMed ID: 21840083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease.
    Niveloni S; Sugai E; Cabanne A; Vazquez H; Argonz J; Smecuol E; Moreno ML; Nachman F; Mazure R; Kogan Z; Gomez JC; Mauriño E; Bai JC
    Clin Chem; 2007 Dec; 53(12):2186-92. PubMed ID: 17901114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin G (IgG) anti-tissue transglutaminase antibodies used as markers for IgA-deficient celiac disease patients.
    Dahlbom I; Olsson M; Forooz NK; Sjöholm AG; Truedsson L; Hansson T
    Clin Diagn Lab Immunol; 2005 Feb; 12(2):254-8. PubMed ID: 15699419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.